- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Apr 10, 2026)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Apr 13, 2026 | T-3987-25 | CMC | Surewerx Usa Inc. Et Al. V 1307386 B.c. Ltd. D/b/a Summit Tools Et Al. (Trade Mark) | Toronto | 30 m |
| Apr 14, 2026 | T-2479-25 | CMC | New Veer Preet Service Centre Inc. V. Veer Preet Transport Ltd. (Trade Mark) | Ottawa | 1 h |
| Apr 14, 2026 | A-288-25 | APP | Mccain Foods Limited V. J.r. Simplot Company Et Al. (Patent) | Ottawa | 0 |
| Apr 14, 2026 | T-2175-25 | M | La Maison Notariale Inc. C. Derhy L�gal Inc. (unknown) | Montréal | 1 h |
| Apr 14, 2026 | T-2352-24 | CMC | Fittes Canada Inc. Et Al. V. Inte-grates Incorporated (Patent) | Toronto | 1 h |
| Apr 14, 2026 | T-2991-24 | CMC | Fittes Canada Inc. Et Al. V. Zion Building Supplies Ltd. (Patent) | Toronto | 1 h |
| Apr 14, 2026 | T-846-26 | CMC | Novartis Pharmaceuticals Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Sacubitril*) | Toronto | 1 h |
| Apr 15, 2026 | T-4811-25 | JR | Nielson Consumer Llc V. The Toronto-dominion Bank (Trade Mark - JR) | Ottawa | 2 h |
| Apr 15, 2026 | T-1266-26 | CMC | Genentech, Inc. And Hoffmann-la Roche Limtited V. Biosimilar Collaborations Ireland Limited (Patent) | Toronto | 1 h |
| Apr 15, 2026 | T-4090-25 | CMC | Fci Holdings Delaware, Llc Et Al V. Normet Canada Ltd. Et Al (Patent) | Toronto | 1 h |
| Apr 16, 2026 | T-662-25 | PTC | Scott Norsworthy V. 2477327 Ontario Inc. C.o.b. As Tiltco Et Al. (Copyright) | Toronto | 15 m |
| Apr 16, 2026 | T-4400-25 | M | Maxunitech North America, Inc. Et Al. V. Nufarm Limited Et Al. (Patent) | Toronto | 2 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Aug 17, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 17, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 17, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 24, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 4 d |
| Aug 31, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 4 d |
| Sep 8, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 4 d |
| Sep 8, 2026 | T-7-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-8-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-9-25 | Aragon Pharmaceuticals, Inc. Et Al. V. Sandoz Canada Inc. (Patent - Apalutamide*) | Toronto | 3 d |
| Sep 8, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 14, 2026 | T-1567-24 | Justin Stitches Inc. V. Makers Holdings Inc. (Trade Mark) | Vancouver | 5 d |
| Sep 14, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 16, 2026 | T-1142-18 | Navtech Inc. V. Chantier Davie Canada Inc. (unknown) | Québec | 2 d |
| Sep 21, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 4 d |
| Sep 28, 2026 | T-75-25 | Boehringer Ingelheim(canada) Ltd. Et Al V.laboratoire Riva Inc (Patent - Empagliflozin*) | Toronto | 2 d |
| Oct 19, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 10 d |
| Oct 19, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Oct 26, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 4 d |
| Nov 4, 2026 | T-1059-22 | Seylynn (north Shore) Development Limited Partnership V. Denna Homes Group (Trade Mark) | Vancouver | 2 d |
| Nov 9, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 12, 2026 | T-2593-24 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Macitentan*) | Toronto | 2 d |
| Nov 18, 2026 | T-451-20 | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 2 d |
| Nov 23, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 8 d |
| Nov 23, 2026 | T-887-25 | Boehringer Ingelheim (canada) Ltd Et Al V. Auro Pharma Inc (Patent - Empagliflozin*) | Toronto | 13 d |
| Nov 23, 2026 | T-1818-23 | The Bank Of Nova Scotia V. Invesco Canada Ltd. (Trade Mark) | Toronto | 5 d |
| Dec 2, 2026 | T-1818-23 | The Bank Of Nova Scotia V. Invesco Canada Ltd. (Trade Mark) | Toronto | 2 d |
| Dec 7, 2026 | T-742-25 | Salix Pharmaceuticals, Inc. V. Sandoz Canada Inc. (Patent) | Toronto | 2 d |
| Dec 17, 2026 | T-887-25 | Boehringer Ingelheim (canada) Ltd Et Al V. Auro Pharma Inc (Patent - Empagliflozin*) | Toronto | 2 d |
| Jan 18, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Jan 25, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 4 d |
| Feb 3, 2027 | T-1792-21 | Tanja Porcnik V. Cato Institute Et Al. (Copyright) | Toronto | 2 d |
| Mar 10, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 10 d |
| Mar 10, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 10 d |
| Mar 30, 2027 | T-2505-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent - Trametinib*) | To be determined (TrialJA) | 2 d |
| Mar 30, 2027 | T-2504-25 | Novartis Pharmaceuticals Canada Inc Et Al. V. Apotex Inc. (Patent) | To be determined (TrialJA) | 2 d |
| Apr 19, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| Apr 26, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 4 d |
| May 10, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 4 d |
| May 10, 2027 | T-3096-25 | Astrazeneca Canada Inc. Et Al. V. Cipla Ltd. (Patent - Olaparib*) | To be determined (TrialJA) | 2 d |
| May 17, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 3 d |
| May 25, 2027 | T-3206-25 | Leo Pharma Inc. Et Al. V. Glenmark Pharmaceuticals Canada Inc. (Patent - Calcipotriol*) | Toronto | 2 d |
| Jun 22, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 9 d |
| Jun 28, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 3 d |
| Jul 2, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 5 d |
| Jul 7, 2027 | T-3922-25 | Astrazeneca Canada Inc. Et Al. V. Natco Pharma (canada) Inc. (Patent - Olaparib*) | Ottawa | 2 d |
| Jul 15, 2027 | T-3739-25 | Novartis Pharmaceuticals Canada Inc V. Pharmascience Inc. Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Aug 9, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 10 d |
| Aug 26, 2027 | T-4459-25 | Novartis Pharmaceuticals Canada Inc. V. Dr. Reddy's Laboratories Ltd. Et Al. (Patent - Ruxolitinib*) | Ottawa | 2 d |
| Sep 7, 2027 | T-4989-25 | Lundbeck Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Vortioxetine*) | Ottawa | 9 d |
| Sep 7, 2027 | T-4796-25 | Lundbeck Canada Inc. Et Al. V. Teva Canada Limited (Patent - Vortioxetine*) | Ottawa | 9 d |
| Sep 20, 2027 | T-78-26 | Novartis Pharmaceuticals Canada Inc. V. Teva Canada Limited Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 10 d |
| Sep 23, 2027 | T-4989-25 | Lundbeck Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Vortioxetine*) | Ottawa | 2 d |
| Sep 23, 2027 | T-4796-25 | Lundbeck Canada Inc. Et Al. V. Teva Canada Limited (Patent - Vortioxetine*) | Ottawa | 2 d |
| Oct 7, 2027 | T-78-26 | Novartis Pharmaceuticals Canada Inc. V. Teva Canada Limited Et Al. (Patent - Ruxolitinib*) | To be determined (TrialJA) | 2 d |
| Oct 19, 2027 | T-846-26 | Novartis Pharmaceuticals Canada Inc. Et Al. V. Zydus Lifesciences Limited (Patent - Sacubitril*) | Ottawa | 8 d |
| Nov 8, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 10 d |
| Nov 24, 2027 | T-323-26 | Lundbeck Canada Inc. Et Al. V. Laboratoire Riva Inc. (Patent - Vortioxetine*) | To be determined (TrialJA) | 2 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Apr 15, 2026 | T-4811-25 | Nielson Consumer Llc V. The Toronto-dominion Bank | Trade Mark - Appeal of a decision of the Registrar | Ottawa | 2 h |
| May 25, 2026 | T-165-25 | Mallinckrodt Hospital Products Inc. V. Agc | Others - Crown (v. Crown) [Applications] | Toronto | 1 d |
| May 26, 2026 | T-1160-24 | Martinizing International, Llc V. C&d Makridis Holdings Ltd. | Trade Mark Infringement | Toronto | 1 d |
| Jun 8, 2026 | T-1895-23 | Smart And Biggar Llp V. Ctc Brand Corp. | Trade Mark Infringement | Toronto | 1 d |
| Jun 9, 2026 | T-1758-22 | Remitbee Incorporated V. Remitly, Inc. | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 2 d |
| Jun 9, 2026 | T-2621-23 | Remitbee Incorporated V. Remitly, Inc. | Trade Mark - Appeal of a decision of the Registrar | Vancouver | 2 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location |
| Apr 14, 2026 | A-288-25 | Mccain Foods Limited V. J.r. Simplot Company Et Al. | Appeal (S.27 - Final) - Patent Act [from T-1624-17 - Patent Infringement] | Ottawa |
| Apr 20, 2026 | A-24-25 | John Zanin V. Ooma, Inc. Et Al | Appeal (S.27 - Interloc.) - Others [from T-214-21 - Others - not provided for anywhere else [Actions]] | Montréal |
| May 27, 2026 | A-254-25 | Bell Canada Et Al. V. Copyright Collective Of Canada Et Al. | S.28 Copyright Board | Ottawa |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.